Rheumatologists' knowledge of contraception, teratogens, and pregnancy risks.

Journal Article (Journal Article)

INTRODUCTION: Rheumatologists are essential partners in planning and managing pregnancies in women with lupus. Whether they know the essentials of contraceptive and medical treatment in pregnancy, however, is unknown. METHOD: Anonymous in-lecture surveys were completed by 270 rheumatologists to assess knowledge of contraceptive effectiveness, emergency contraception, medication teratogenicity, and lupus pregnancy risk assessment. RESULTS: Rheumatologists knew the high effectiveness of the intrauterine device, but over-estimated the effectiveness of injectable medroxyprogesterone and condoms. Almost all identified methotrexate as a teratogen, but only 69% identified cyclophosphamide and 37% mycophenolate. Most rheumatologists knew that lupus activity in pregnancy is the main predictor of pregnancy outcomes, but underestimated the risks of hypertension and race. CONCLUSION: To improve lupus pregnancy planning and management, rheumatologists would benefit from improved knowledge about contraceptive effectiveness, teratogens, and the risks from non-lupus factors for pregnancy complications.

Full Text

Duke Authors

Cited Authors

  • Clowse, ME; Eudy, AM; Revels, J; Sanders, GD; Criscione-Schreiber, L

Published Date

  • December 2018

Published In

Volume / Issue

  • 11 / 4

Start / End Page

  • 182 - 185

PubMed ID

  • 30574180

Pubmed Central ID

  • PMC6295764

International Standard Serial Number (ISSN)

  • 1753-495X

Digital Object Identifier (DOI)

  • 10.1177/1753495X18771266


  • eng

Conference Location

  • England